Autosomal Semi-dominant Severe Lipodystrophic Laminopathy
Genes related to Autosomal Semi-dominant Severe Lipodystrophic Laminopathy
- LMNA
Clinical Features
Top most frequent phenotypes and symptoms related to Autosomal Semi-dominant Severe Lipodystrophic Laminopathy
- Micrognathia
- Hepatomegaly
- Myopathy
- Congestive heart failure
- Splenomegaly
- Diabetes mellitus
- Myalgia
- Hypertrophic cardiomyopathy
- Hepatic steatosis
- Round face
And another 39 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Autosomal Semi-dominant Severe Lipodystrophic Laminopathy Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
CMT Advanced Evaluation - Dominant, Axonal.
By Athena Diagnostics Inc (United States).
YARS, MFN2, TRPV4, DNM2, HSPB8, GARS, HSPB1, LMNA, MPZ, NEFL, RAB7A
Specificity
10 %
Genes
100 % |
CMT Advanced Evaluation - Comprehensive.
By Athena Diagnostics Inc (United States).
YARS, PRX, GDAP1, LITAF, FIG4, MFN2, TRPV4, FGD4, SBF2, SH3TC2, DNM2, HSPB8, EGR2, GARS, GJB1, HSPB1, LMNA, MPZ, MTMR2, NDRG1 , (...)
View the complete list with 3 more genes
Specificity
5 %
Genes
100 % |
CMT Advanced Evaluation - Axonal.
By Athena Diagnostics Inc (United States).
YARS, GDAP1, MFN2, TRPV4, DNM2, HSPB8, GARS, GJB1, HSPB1, LMNA, MPZ, NEFL, RAB7A
Specificity
8 %
Genes
100 % |
CMT Advanced Evaluation - Recessive.
By Athena Diagnostics Inc (United States).
PRX, GDAP1, FIG4, FGD4, SBF2, SH3TC2, LMNA, MTMR2, NDRG1
Specificity
12 %
Genes
100 % |
LMNA (CMT2B1) DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
LMNA
Specificity
100 %
Genes
100 % |
Lamin A/C (LMNA) DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
LMNA
Specificity
100 %
Genes
100 % |
CMT Advanced Evaluation - Nonprevalent.
By Athena Diagnostics Inc (United States).
YARS, PRX, GDAP1, LITAF, FIG4, TRPV4, FGD4, SBF2, SH3TC2, DNM2, HSPB8, EGR2, GARS, GJB1, HSPB1, LMNA, MTMR2, NDRG1, NEFL, PMP22 , (...)
View the complete list with 1 more genes
Specificity
5 %
Genes
100 % |
Emery-Dreifuss Muscular Dystrophy Advanced Sequencing Evaluation.
By Athena Diagnostics Inc (United States).
SYNE2, SYNE1, TMEM43, EMD, FHL1, LMNA
Specificity
17 %
Genes
100 % |
You can get up to 442 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SCHIZOPHRENIA; SCZD DESMOSTEROLOSIS LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C; CMTRIC GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF